Comparisons of efficacy and tolerance of moricizine with other antiarrhythmic agents in the treatment of chronic ventricular arrhythmias
- PMID: 2106254
- DOI: 10.1016/0002-9149(90)91415-3
Comparisons of efficacy and tolerance of moricizine with other antiarrhythmic agents in the treatment of chronic ventricular arrhythmias
Abstract
Comparative trials of a new drug with standard antiarrhythmic agents are important for establishing relative efficacy and tolerance. For moricizine, such trials have included comparisons with propranolol, disopyramide and quinidine. Furthermore, the Cardiac Arrhythmia Pilot Study compared moricizine in postinfarction patients with encainide and flecainide. These trials show moricizine to be superior in efficacy to a beta blocker (propranolol) and disopyramide and equivalent to quinidine. Although the class IC drugs (encainide and flecainide) showed somewhat greater efficacy in the Cardiac Arrhythmic Pilot Study, they are now known to increase the risk of mortality in postinfarction patients. Moricizine was also shown to be well tolerated in these trials and associated with fewer discontinuations than propranolol, disopyramide and quinidine. Thus, moricizine is a promising new agent when profiled against other drugs frequently used for therapy of chronic ventricular arrhythmias.
Similar articles
-
Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS.Am J Cardiol. 1988 Mar 1;61(8):501-9. doi: 10.1016/0002-9149(88)90754-0. Am J Cardiol. 1988. PMID: 2894169 Clinical Trial.
-
Antiarrhythmic efficacy of Ethmozine (moricizine HCl) compared with disopyramide and propranolol.Am J Cardiol. 1987 Oct 16;60(11):52F-58F. doi: 10.1016/0002-9149(87)90722-3. Am J Cardiol. 1987. PMID: 3310586 Clinical Trial.
-
Antiarrhythmic agents for chronic ventricular arrhythmias.Compr Ther. 1987 Apr;13(4):26-35. Compr Ther. 1987. PMID: 3105950 Review.
-
CAST and beyond. Implications of the cardiac arrhythmia suppression trials. By the Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.Eur Heart J. 1990 Mar;11(3):194-9. Eur Heart J. 1990. PMID: 2108031 Clinical Trial. No abstract available.
-
CAST and beyond. Implications of the Cardiac Arrhythmia Suppression Trial. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.Circulation. 1990 Mar;81(3):1123-7. doi: 10.1161/01.cir.81.3.1123. Circulation. 1990. PMID: 1689621 Review. No abstract available.
Cited by
-
Effects of intravenous dofetilide in patients with frequent premature ventricular contractions: a clinical trial.Clin Cardiol. 2000 Jun;23(6):415-6. doi: 10.1002/clc.4960230607. Clin Cardiol. 2000. PMID: 10875030 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical